Authors


Don DeCou, PhD

Latest:

A Study of Leachables for Biopharmaceutical Formulations Stored in Rubber-Stoppered Glass Vials

A systematic approach facilitates formulation component selection.


Subhasis Banerjee

Latest:

Review of SUT Adoption in Biopharma Manufacturing

The evolution of therapeutic modalities drives the adoption of single-use technologies.


Blanca Lain, PhD

Latest:

PEG Precipitation: A Powerful Tool for Monoclonal Antibody Purification

This alternative purification method to chromatography is readily scalable and fits a fully disposable downstream process.




Yelena Bisharyan

Latest:

An Alternative Platform for Rapid Production of Effective Subunit Vaccines

Adjuvant activity can be greatly improved by appropriate formulation of cytosine-phosphorothioate-guanine oligodeoxynucleotides (CpG ODNs).


Alberta Di Pasquale, PhD

Latest:

Addressing Unmet Medical Needs Through Tailored Vaccine Design: The Importance of Adjuvant Systems

It is now possible to combine antigens with specific adjuvant systems to create more effective vaccines.



Bob Kruse, PhD

Latest:

Meningitis Vaccine Manufacturing: Fermentation Harvest Procedures Affect Purification

Careful analysis of an unusual precipitate identifies defects.


Graham Clapperton

Latest:

Quality Management Systems for Small Biopharmaceutical Organizations

What small biotechs need to know about quality management systems.


L. Winberry, PhD

Latest:

Effective Auditing of CMOs

It is important that all stages of the audit be given an equal measure of attention.


Stuart Feldman

Latest:

Quality by Design for Biotechnology Products—Part 3

Regulatory flexibility can make continuous improvement possible.


Darón I. Freedberg

Latest:

Using NMR Spectroscopy to Obtain the Higher Order Structure of Biopharmaceutical Products

Simple methods can characterize polysaccharide vaccines and recombinant cytokines at high resolution.


Lois Atkins

Latest:

Quality by Design for Biotechnology Products—Part 3

Regulatory flexibility can make continuous improvement possible.




Bernerd McGarvey

Latest:

Quality by Design for Biotechnology Products—Part 3

Regulatory flexibility can make continuous improvement possible.


Kevin Harper

Latest:

A Review of Sterile Connectors

Many factors must be considered when choosing a sterile connector for a given process.


Bhawani Mukherjee

Latest:

Manufacturing Vaccines for the Developing World

A handful of facilities making 200 million single-dose units per year could fast-track the immunization of the developing world.



Tony Lubiniecki

Latest:

Quality by Design for Biotechnology Products—Part 3

Regulatory flexibility can make continuous improvement possible.


Paul Smock

Latest:

Quality by Design for Biotechnology Products—Part 3

Regulatory flexibility can make continuous improvement possible.


David Simpson

Latest:

Advancing Vaccine Technology to Combat Global Pandemic Threats

New technologies such as virus-like particles are promising weapons in the battle against pandemic influenza.


Janice Lim, PhD

Latest:

An Economic Comparison of Three Cell Culture Techniques

Comparing the economic feasibility of a typical glycosylated protein.


Paul Colussi

Latest:

An Alternative Platform for Rapid Production of Effective Subunit Vaccines

Adjuvant activity can be greatly improved by appropriate formulation of cytosine-phosphorothioate-guanine oligodeoxynucleotides (CpG ODNs).



Qiang Qin, PhD

Latest:

Analytical Tools for Process and Product Characterization

Select the best approach to determine critical quality attributes.



Jutta Look

Latest:

Quality by Design for Biotechnology Products—Part 3

Regulatory flexibility can make continuous improvement possible.


Esam Abdelgadir

Latest:

Scale-Up and Comparison Studies Evaluating Disposable Bioreactors and Probes

Process performance was comparable across all scales, and fiber optic sensors appeared interchangeable with conventional probes.

© 2024 MJH Life Sciences

All rights reserved.